SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 47.82
-0.50 (-1.03%)
May 18, 2026, 4:00 PM EDT
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 3.78 billion as of May 18, 2026. Its market cap has increased by 74.52% in one year.
Market Cap
3.78B
Enterprise Value
3.20B
Revenue
860.07M
Ranking
n/a
PE Ratio
33.01
Stock Price
47.82
Market Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has decreased from 4.48B to 3.78B, a decrease of -15.64%. That is a compound annual growth rate of -4.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 3.78B | -8.11% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 7.83B |
| Beijing Strong Biotechnologies,Inc. | 7.64B |
| Maccura Biotechnology Co.Ltd | 6.25B |
| Cowealth Medical China | 5.76B |
| Thalys Medical Technology Group | 4.47B |
| Shanghai Labway Clinical Laboratory | 4.24B |
| Guangdong Hybribio Biotech | 3.96B |
| Medicalsystem Biotechnology | 3.85B |